椎旁阻滞不降低肺癌术后复发但与更高总生存相关
该回顾性队列研究纳入2009至2013年开胸肺癌根治术患者,按术后镇痛方式分为PCA组(n=574)、胸段硬膜外镇痛组(TEA,n=619)和椎旁阻滞组(PVB,n=536)。经倾向评分匹配调整混杂后,PVB组总生存优于PCA组和TEA组,但三种镇痛方式与无复发生存均无显著关联。
要点
- PVB与肺癌术后更高总生存相关,但镇痛方式与肿瘤复发无显著关联。
- 倾向评分匹配后PVB对比PCA的死亡风险比为0.66(95%CI 0.46-0.94)。
- 倾向评分匹配后PVB对比TEA的死亡风险比为0.65(95%CI 0.48-0.89)。
核心结论
- 镇痛方式与肺癌术后肿瘤复发无显著关联,但PVB可能与肺癌患者总生存改善相关。
研究设计与样本
- 回顾性队列研究,分析2009至2013年单家三级医院开胸肺癌根治术患者记录。
- 按术后镇痛方式分为PCA组(n=574)、TEA组(n=619)和PVB组(n=536)。
- 采用多因素Cox比例风险模型和log-rank检验,并以倾向评分匹配调整混杂因素。
主要发现
- 倾向评分匹配后,PVB对比PCA的风险比为0.66(95%CI 0.46-0.94),对比TEA为0.65(95%CI 0.48-0.89)。
临床怎么用
- 对于开胸肺癌根治术患者,选择PVB可能有助于改善总生存,但不应期望其降低肿瘤复发。
- 镇痛方式的选择仍需结合患者具体情况和临床条件个体化决定。
局限性
- 本研究为单中心回顾性队列研究,可能存在未测量混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postoperative analgesic methods are suggested to have an impact on long-term prognosis after cancer surgery through opioid-induced immune suppression. We hypothesized that regional analgesia that reduces the systemic opioid requirement would be related to lower cancer recurrence and higher overall survival compared to intravenous patient-controlled analgesia (PCA) for lung cancer surgery. METHODS: Records for all patients who underwent open thoracotomy for curative resection of primary lung cancer between 2009 and 2013 in a tertiary care hospital were retrospectively analyzed. Patients were divided by postoperative analgesic methods: PCA (n = 574), thoracic epidural analgesia (TEA, n = 619), or paravertebral block (PVB, n = 536). Overall and recurrence-free survivals were compared among 3 analgesic methods via a multivariable Cox proportional hazard model and a log-rank test after adjusting confounding factors using propensity score matching (PSM). RESULTS: Analgesic method was associated with overall survival (P= .0015; hazard ratio against TEA [95% confidence intervals]: 0.58 [0.39-0.87] for PCA, 0.60 [0.45-0.79] for PVB). After confounder adjustment using PSM, PVB showed higher overall survival than PCA (log-rank P= .0229) and TEA (log-rank P= .0063) while PCA and TEA showed no difference (log-rank P= .6). Hazard ratio for PVB was 0.66 [0.46-0.94] against PCA and 0.65 [0.48-0.89] against TEA after PSM. However, there was no significant association between the analgesic methods and recurrence-free survival (P= .5; log-rank P with PSM = .5 between PCA and TEA, .5 between PCA and PVB, .1 between TEA and PVB). CONCLUSIONS: Pain-control methods are not related to cancer recurrence. However, PVB may have a beneficial effect on overall survival of patients with lung cancer.
引用
- Lee EK, Ahn HJ, Zo JI, et al. Paravertebral Block Does Not Reduce Cancer Recurrence, but Is Related to Higher Overall Survival in Lung Cancer Surgery: A Retrospective Cohort Study. Anesth Analg. 2017. PMID: 28857802. doi:10.1213/ANE.0000000000002342
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。